Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed toward growing the horizons of cytokine-based immunotherapy, especially for cancers where cure solutions remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/moneygram-names-luke-tuttle-as-chief-technology-officer/